Wtvq iconWtvqAug 7, 2026

New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine

WASHINGTON (AP) — The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic, manufacturer Moderna said. Other brands of flu shots already have begun arriving in pharmacies ahead of fall...

New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine

Share this story

Send the public story page.

Useful takeaways from this story.

WASHINGTON (AP) — The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic,...

Other brands of flu shots already have begun arriving in pharmacies ahead of fall...

The shot, named mFlusiva, is intended for adults age 50 or older.

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

WASHINGTON (AP) — The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic, manufacturer Moderna said. Other brands of flu shots already have begun arriving in pharmacies ahead of fall... The shot, named mFlusiva, is intended for adults age 50 or older.

Details worth keeping

The shot, named mFlusiva, is intended for adults age 50 or older.

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app